Counterfeit Lipitor

FDA Alerts Consumers and Health Professionals to Recall of Counterfeit Lipitor

FDA Alerts Consumers and Health Professionals to Recall of Counterfeit Lipitor

 The Food and Drug Administration (FDA) today announced that Albers Medical Distributors, Inc., has voluntarily recalled three lots of 90-count bottles of the cholesterol-lowering drug Lipitor and is warning healthcare providers and others that these three lots of counterfeit Lipitor represent a potentially significant risk to consumers. The product was repackaged by Med-Pro, Inc., of Lexington, Neb., and the labels say "Repackaged by: MED-PRO, Inc. Lexington, Neb." in the lower left-hand corner. The following lots are involved in this recall: 20722V – 90-tablet bottles, Expiration 09-2004 04132V – 90-tablet bottles, Expiration 01-2004 16942V – 90-tablet bottles, Expiration 09-2004